DM
APLT

Deerfield Management’s Applied Therapeutics APLT Stock Holding History

Deerfield Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-278,359
Closed -$10.1M – 106
2020
Q2 		$10.1M Hold
278,359
– – 0.29% 77
2020
Q1 		$9.1M Buy
+278,359
New +$11.3M 0.29% 71

Other funds holding APLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Deerfield Management's APLT Position: Q3 2020 in Review

Deerfield Management sold out of Applied Therapeutics (APLT) in Q3 2020, closing a stake of 278,359 shares — an estimated $10.1M sold.

Deerfield Management first reported a position in APLT in Q1 2020 and held it in 2 quarters. The position peaked at $10.1M in Q2 2020. 66 funds tracked by Wall St. Rank hold APLT as of Q3 2020.

  • Deerfield Management reported no remaining Applied Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Deerfield Management sold 278,359 Applied Therapeutics shares in Q3 2020, an estimated $10.1M.
  • Deerfield Management first reported a position in Applied Therapeutics in Q1 2020 and held it in 2 quarters.
  • Deerfield Management's Applied Therapeutics position peaked at $10.1M in Q2 2020.
  • 66 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2020.

Based on Deerfield Management's 13F filing for Q3 2020, filed 16 Nov 2020.